Tkaczuk, K. H., Scilla, K. A., Rao, G. G., Jiang, Y., Mehra, R., Roque, D. M., Hausner, P. F., Tait, N., Serrero, G., Yue, B. (2026). Phase 1 first-in-human trial of AG01, a recombinant humanized monoclonal antibody to progranulin/glycoprotein 88 (GP88) to determine the safety, tolerability, pharmacokinetics, and preliminary antitumor activity in subjects with advanced solid tumor malignancies.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps2669